tiprankstipranks
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
PremiumPress ReleasesMinerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
2M ago
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
PremiumThe Fly
Minerva reports Q4 EPS ($1.19) vs. ($1.26) last year
2M ago
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
PremiumPress Releases
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
6M ago
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
PremiumPress ReleasesMinerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
9M ago
Minerva prices 1.425M shares at $10.00 in private placement
PremiumThe Fly
Minerva prices 1.425M shares at $10.00 in private placement
10M ago
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
PremiumPress Releases
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
10M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
12M ago
Minerva announces U.S. FDA filed NDA for roluperidone
PremiumThe Fly
Minerva announces U.S. FDA filed NDA for roluperidone
12M ago
Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
PremiumPress Releases
Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100